Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of IV tPA in Stroke on Awakening (SAIL-ON)
NCT01643902Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Jan 2013
- Primary completion
- Dec 2015
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tissue-plasminogen activator in ischemic stroke, sponsored by Johns Hopkins University. Primary endpoint: Symptomatic Intracerebral Hemorrhage at 36 hours. Started Jan 2013; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01643902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01643902.